Skip to main
CANF

CANF Market Capitalization Overview

Market Cap: $36.10K as of Jan 9, 2026

$36.10K
$10.60K (41.57%)past month
As of Jan 9, 2026, CANF has a market capitalization of $36.10K. Over the past 30 days, its market cap has decreased by -43.27%, while in the last 12 months, it has increased by 105.11%.

Market capitalization represents the total value of Can-Fite BioPharma Ltd. as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

CANF Market Cap Formula = Stock Price * Shares Outstanding

The market cap of CANF helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CANF Market Cap History

DateMarket CapChange
Dec 1, 2025$34.21K-5.79%
Nov 3, 2025$36.31K-32.90%
Oct 1, 2025$54.10K-7.36%
Sep 2, 2025$58.40K+0.86%
Aug 1, 2025$57.90K-36.86%
Jul 1, 2025$91.70K-0.97%
Jun 30, 2025$92.60K

CANF End of Year Market Cap History

DateMarket CapChange
2026$36.10K+105.11%
2025$17.61K

FAQs About Can-Fite BioPharma Ltd. (CANF) Market Cap

As of Jan 9, 2026, the market capitalization of CANF is $36.10K. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Can-Fite BioPharma Ltd.’s market capitalization has increased by 41.57%, changing from $25.50K to $36.10K as of Jan 9, 2026.

In the last 3 months, Can-Fite BioPharma Ltd.’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Can-Fite BioPharma Ltd.’s market capitalization increased from – in January to $17.61K in December, reflecting a — change.

Can-Fite BioPharma Ltd. (CANF)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.